Abciximab Therapy and Unplanned Coronary Stent Deployment
Data up to Jan 2025
Total Citations Per Year
Abstract
References (18)
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 • 2,614 citations
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
1988 • 2,128 citations
A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents
1996 • 2,032 citations
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 • 1,922 citations
Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries
1996 • 404 citations
Practice Strategies for Elective Red Blood Cell Transfusion
1992 • 334 citations
A Randomized Comparison of Combined Ticlopidine and Aspirin Therapy Versus Aspirin Therapy Alone After Successful Intravascular Ultrasound–Guided Stent Implantation
1996 • 287 citations
Guidelines for percutaneous transluminal coronary angioplasty
1993 • 233 citations
Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial)
1995 • 148 citations
Coronary Stent Placement in Patients With Acute Myocardial Infarction: Comparison of Clinical and Angiographic Outcome After Randomization to Antiplatelet or Anticoagulant Therapy
1997 • 132 citations
“Rescue” Utilization of Abciximab for the Dissolution of Coronary Thrombus Developing as a Complication of Coronary Angioplasty
1997 • 106 citations
In Vitro Effects of the Platelet Glycoprotein IIb/IIIa Receptor Antagonist c7E3 Fab on the Activated Clotting Time
1997 • 93 citations
Major Benefit From Antiplatelet Therapy for Patients at High Risk for Adverse Cardiac Events After Coronary Palmaz-Schatz Stent Placement
1997 • 93 citations
Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting
1996 • 62 citations
Results of coronary stenting for unstable versus stable angina pectoris
1997 • 47 citations
Partial Reversal of Heparin Anticoagulation by Intravenous Protamine in Abciximab-Treated Patients Undergoing Percutaneous Intervention
1997 • 35 citations
Abstract
1997 • 1 citations
Abstract
1997 • 1 citations